Clinical Trial Update: Oral L-carnitine and Inflammatory and Nutritional Biomarkers in Maintenance Hemodialysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining oral L-carnitine and inflammatory and nutritional biomarkers in maintenance hemodialysis to assess effects on ESRD pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Darya Chamani | Conditions: End-stage Renal Disease (ESRD), Hemodialysis | Phase 2 | Status: COMPLETED